Načítá se...
Tranexamic acid in traumatic brain injury: an explanatory study nested within the CRASH-3 trial
PURPOSE: The CRASH-3 trial is a randomised trial of tranexamic acid (TXA) on death and disability in patients with traumatic brain injury (TBI). It is based on the hypothesis that early TXA treatment can prevent deaths from post-traumatic intracranial bleeding. The results showed that timely TXA tre...
Uloženo v:
| Vydáno v: | Eur J Trauma Emerg Surg |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Springer Berlin Heidelberg
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7851008/ https://ncbi.nlm.nih.gov/pubmed/32076783 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00068-020-01316-1 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|